Growth Metrics

Lifeward (LFWD) Long-Term Deferred Tax (2018 - 2020)

Lifeward recorded quarterly Long-Term Deferred Tax of $287000.0 in Q4 2020, up 18.11% quarter-over-quarter from $243000.0 in Q4 2019, and up 18.11% year-over-year from $243000.0 in Q1 2020.

Lifeward's Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $287000.0 for Q4 2020.

  • In Q4 2020, Long-Term Deferred Tax rose 18.11% year-over-year to $287000.0; the TTM figure through Dec 2020 stood at $287000.0 (up 18.11% YoY), while the FY2020 annual figure was $287000.0, up 18.11% from the prior year.
  • Long-Term Deferred Tax came in at $287000.0 for Q4 2020 at Lifeward, up from $243000.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $287000.0 in Q4 2020 to a low of $186000.0 in Q4 2018.
  • A 3-year average of $238666.7 and a median of $243000.0 in 2019 frame the typical range for Long-Term Deferred Tax.
  • Across the five-year window, Long-Term Deferred Tax soared 30.65% in 2019 and advanced 18.11% in 2020, its largest moves.
  • Lifeward's Long-Term Deferred Tax stood at $186000.0 in 2018, then surged by 30.65% to $243000.0 in 2019, then rose by 18.11% to $287000.0 in 2020.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $287000.0, $243000.0, and $186000.0 for Q4 2020, Q4 2019, and Q4 2018 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Lifeward 5.59 Mn -5.81 Mn 1.34 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2020 43.23 Mn
Dec 31, 2019 243,000.00
Dec 31, 2018 29.84 Mn